480
Participants
Start Date
November 6, 2024
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
VDPHL01
VDPHL01 Extended Release (ER) Tablet
Placebo
Placebo
Site 38, New York
Site 37, Kew Gardens
Site 08, Broomall
Site 10, Plymouth Meeting
Site 29, Lynchburg
Site 20, Greensville
Site 43, Atlanta
Site 42, Hollywood
Site 17, Aventura
Site 25, Brandon
Site 03, Tampa
Site 36, Birmingham
Site 16, Murfreesboro
Site 04, Nashville
Site 09, Knoxville
Site 11, Columbus
Site 39, Boardman
Site 15, Indianapolis
Site 32, New Albany
Site 27, West Lafayette
Site 26, Clarkston
Site 06, New Brighton
Site 23, Rolling Meadows
Site 12, Metairie
Site 13, Covington
Site 41, Baton Rouge
Site 35, Rogers
Site 30, Fort Smith
Site 44, Dallas
Site 14, Houston
Site 40, Bellaire
Site 05, Castle Rock
Site 24, Englewood
Site 31, Boise
Site 19, West Jordan
Site 28, Phoenix
Site 34, Sherman Oaks
Site 21, Vista
Site 07, Fountain Valley
Site 02, Fremont
Site 33, Seattle
Site 01, Spokane
Site 22, Brighton
Site 18, Hackensack
Veradermics, Inc.
INDUSTRY